Evidence map›Paper›PMID 24728176›Full record

ArticleCarcinogenesis2014

ATM-mediated Mad1 Serine 214 phosphorylation regulates Mad1 dimerization and the spindle assembly checkpoint.

Chunying Yang, Jianwei Hao, Dejuan Kong, Xiaoli Cui, Wei Zhang, Haibo Wang, Xiaojing Guo, Shumei Ma, Xiaodong Liu, Peiyu Pu and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. MAD1: Kinetochore Receptors and Catalytic Mechanisms.Frontiers in cell and developmental biology · 2018
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Elevated Aurora B expression contributes to chemoresistance and poor prognosis in breast cancer.International journal of clinical and experimental pathology · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Chunying YangDepartment of Radiation Oncology, Houston Methodist Hospital Research Institute, Houston, TX 77030, USA, Department of Oncology, Drug Discovery Division, Southern Research Institute, Birmingham, AL 35205, USA.
Jianwei HaoDepartment of Radiation Oncology, Houston Methodist Hospital Research Institute, Houston, TX 77030, USA, Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, China.
Dejuan KongDepartment of Radiation Oncology, Houston Methodist Hospital Research Institute, Houston, TX 77030, USA, Laboratory of Radiobiology, Jilin University School of Public Health, Changchun 130001, China.
Xiaoli CuiDepartment of Oncology, Drug Discovery Division, Southern Research Institute, Birmingham, AL 35205, USA.
Wei ZhangDepartment of Medicinal Chemistry, Southern Research Institute, Birmingham, AL 35205, USA and.
Haibo WangDepartment of Radiation Oncology, Houston Methodist Hospital Research Institute, Houston, TX 77030, USA.
Xiaojing GuoDepartment of Radiation Oncology, Houston Methodist Hospital Research Institute, Houston, TX 77030, USA.
Shumei MaLaboratory of Radiobiology, Jilin University School of Public Health, Changchun 130001, China.
Xiaodong LiuLaboratory of Radiobiology, Jilin University School of Public Health, Changchun 130001, China.
Peiyu PuDepartment of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, China.
Bo XuDepartment of Radiation Oncology, Houston Methodist Hospital Research Institute, Houston, TX 77030, USA, Department of Oncology, Drug Discovery Division, Southern Research Institute, Birmingham, AL 35205, USA, Cancer Cell Biology Program, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35205, USA xu@sri.org.
Methodist Hospital · USHouston Methodist · USJilin University · CNSouthern Research Institute · USTianjin Medical University General Hospital · CN

Funding

Mechanisms of Mitotic Activation of the ATM kinaseR01CA133093 · NCI · SOUTHERN RESEARCH INSTITUTE · PI XU, BO · 2009 to 2013
$1.4M
A Novel Pathway Involving ATM, PP1 and I-2R01ES016354 · NIEHS · SOUTHERN RESEARCH INSTITUTE · PI MITRA, SANKAR · 2009 to 2012
$1.1M
An HTS Assay for Inhibitors of NBS1-ATM InteractionsR21NS061748 · NINDS · SOUTHERN RESEARCH INSTITUTE · PI XU, BO · 2007 to 2007
$211k
NCI NIH HHS R01CA133093NIEHS NIH HHS R01ES016354NINDS NIH HHS R21NS061748
6 · The paper itself

Abstract

The spindle assembly checkpoint (SAC), which blocks anaphase onset until all chromosomes have bi-oriented, is one of the key self-monitoring systems of the eukaryotic cell cycle for genome stability. The mitotic arrest-deficient protein 1 (Mad1), a critical component of the SAC, is hyperphosphorylated in mitosis. However, the kinases responsible for Mad1 phosphorylation and its functional significance are not fully understood. Here we report that Mad1 is phosphorylated on Serine 214 by the Ataxia-Telangiectasia Mutated (ATM) kinase, a critical DNA damage response protein also activated in mitosis and required for the SAC. We demonstrate that Mad1 Serine 214 phosphorylation promotes the formation of homodimerization of Mad1 and its heterodimerization with Mad2. Further we show that Mad1 Serine 214 phosphorylation contribute to activation of the SAC and the maintenance of chromosomal stability. Together, these findings reveal an important role of ATM-mediated Mad1 Serine 214 phosphorylation in mitosis.

Indexed as

M Phase Cell Cycle CheckpointsProtein Processing, Post-TranslationalAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsHCT116 CellsHeLa CellsHumansMad2 ProteinsModels, MolecularNuclear ProteinsPhosphorylationProtein MultimerizationProtein Serine-Threonine KinasesProtein Structure, TertiaryAtaxia Telangiectasia Mutated ProteinsATM protein, humanBUB1 protein, humanCell Cycle ProteinsMAD1L1 protein, humanMAD2L1 protein, humanMad2 ProteinsNuclear ProteinsProtein Serine-Threonine Kinases

Identifiers

PMID24728176
PMCPMC4146412
OpenAlexW2112442284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.